Olgun N - Search Results

This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Save citations to file

Email citations

Subject: Olgun N - PubMed

To:

From:

Selection:

Format:

MeSH and other data

Add to Collections

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Results by year

Year	Number of Results
1992	3
1993	5
1994	1
1995	3
1996	1
1997	2
1998	1
1999	1
2000	2
2001	3
2002	3
2003	3
2004	2
2005	3
2006	1
2007	4
2008	6
2009	9
2010	8
2011	8
2012	1
2013	5
2014	9
2015	8
2016	6
2017	6
2018	7
2019	6
2020	6
2021	10
2022	15
2023	7
2024	5

137 results

Page of 14

Results by year

Page 1

Evaluating the Effectiveness of a Training on Ergonomic Risks of Measuring Blood Pressure.

Dіrgar E, Olgun N. Dіrgar E, et al. Among authors: olgun n. Creat Nurs. 2024 May 2:10784535241248065. doi: 10.1177/10784535241248065. Online ahead of print. Creat Nurs. 2024. PMID: 38698300

Infantile Hemangiomas of the Head and Neck: A Single-Center Experience.

Kizmazoglu D, Ince D, Olgun Y, Cecen E, Guleryuz H, Erdag T, Olgun N. Kizmazoglu D, et al. Among authors: olgun n. Children (Basel). 2024 Mar 6;11(3):311. doi: 10.3390/children11030311. Children (Basel). 2024. PMID: 38539346 Free PMC article.

Lithological controls on lake water biogeochemistry in Maritime Antarctica.

Olgun N, Tarı U, Balcı N, Altunkaynak Ş, Gürarslan I, Yakan SD, Thalasso F, Astorga-España MS, Cabrol L, Lavergne C, Hoffmann L. Olgun N, et al. Sci Total Environ. 2024 Feb 20;912:168562. doi: 10.1016/j.scitotenv.2023.168562. Epub 2023 Nov 18. Sci Total Environ. 2024. PMID: 37981135

S-100 and MATH-1 Protein Expressions Can Be Useful for the Prediction of Clinical Outcome in Neuroblastoma Patients.

Sanlav G, Baran B, Kum Özşengezer S, Kizmazoğlu D, Altun Z, Aktaş S, Olgun N. Sanlav G, et al. Among authors: olgun n. J Pediatr Hematol Oncol. 2024 Jan 1;46(1):21-28. doi: 10.1097/MPH.0000000000002783. Epub 2023 Nov 9. J Pediatr Hematol Oncol. 2024. PMID: 37943051

Comparing Tribbles Homolog 3 (TRIB3) Protein Expression Levels with Clinicopathological Characteristics and Survival Among Neuroblastoma Patients.

Baran B, Sanlav G, Kızmazoğlu D, Kum Özşengezer S, Aktaş S, Altun Z, Olgun N. Baran B, et al. Among authors: olgun n. Clin Med Insights Oncol. 2023 Sep 19;17:11795549231199926. doi: 10.1177/11795549231199926. eCollection 2023. Clin Med Insights Oncol. 2023. PMID: 37744426 Free PMC article.

Unraveling the Mystery: Next Generation Sequencing Sheds Light on Neuroblastoma Pathogenesis and Targeted Therapies.

Aktas T, Kızmazoglu D, Aktas S, Erol A, Serinan E, Gokbayrak O, Ozdemir SM, Altun Z, Ozer E, Cecen E, Ince D, Olgun N. Aktas T, et al. Among authors: olgun n. Front Biosci (Landmark Ed). 2023 Aug 17;28(8):171. doi: 10.31083/j.fbl2808171. Front Biosci (Landmark Ed). 2023. PMID: 37664946 Free article.

Pediatric paravertebral tumors: analysis of 96 patients.

Kizmazoglu D, Ince D, Cecen E, Kizmazoglu C, Guleryuz H, Ozer E, Demiral A, Olgun N. Kizmazoglu D, et al. Among authors: olgun n. Childs Nerv Syst. 2024 Jan;40(1):123-133. doi: 10.1007/s00381-023-06064-2. Epub 2023 Jul 15. Childs Nerv Syst. 2024. PMID: 37452862

Systematic review of the potential carcinogenicity of bisphenol A in humans.

Prueitt RL, Hixon ML, Fan T, Olgun NS, Piatos P, Zhou J, Goodman JE. Prueitt RL, et al. Among authors: olgun ns. Regul Toxicol Pharmacol. 2023 Aug;142:105414. doi: 10.1016/j.yrtph.2023.105414. Epub 2023 May 30. Regul Toxicol Pharmacol. 2023. PMID: 37263405 Free article. Review.

Whole-exome sequencing reveals genetic variants in low-risk and high-risk neuroblastoma.

Altun Z, Yuan H, Baran B, Aktaş S, Sönmez EE, Küçük C, Olgun N. Altun Z, et al. Among authors: olgun n. Gene. 2023 Apr 15;860:147233. doi: 10.1016/j.gene.2023.147233. Epub 2023 Feb 2. Gene. 2023. PMID: 36736507

Dinutuximab beta plus conventional chemotherapy for relapsed/refractory high-risk neuroblastoma: A single-center experience.

Olgun N, Cecen E, Ince D, Kizmazoglu D, Baysal B, Onal A, Ozdogan O, Guleryuz H, Cetingoz R, Demiral A, Olguner M, Celik A, Kamer S, Ozer E, Altun Z, Aktas S. Olgun N, et al. Front Oncol. 2022 Dec 23;12:1041443. doi: 10.3389/fonc.2022.1041443. eCollection 2022. Front Oncol. 2022. PMID: 36620564 Free PMC article.

137 results

Page of 14

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

137 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Results by year